Vasomedical, Inc. is a global leader in non-invasive healthcare solutions and products with corporate offices and manufacturing in Westbury, New York. We also have manufacturing facilities in China and sales operations in North Carolina. Our proprietary core product line of Enhanced External Counterpulsation (EECP®) Therapy systems is the leading product in the non-invasive treatment of cardiovascular disease. Vasomedical is the parent company of our operating subsidiaries – Vasomedical Solutions, Vasomedical Global and VasoHealthcare. The Company is listed on the OTCBB under the symbol VASO. The Company is pursuing a strategy of accretive acquisitions in the medical device and health care markets and promoting growth in our core businesses.

*At time of closing.

TRANSACTION SNAPSHOT

Vasomedical

$5 Million plus*

Public Offering

February 2015

GPB Life Science Holdings, LLC

$500,000*

Private Placements

November 2015

Read More

Sino Global Shipping America, Ltd.

$5 Million*

Public Offering

January 2015

Read More

Grom Social, Inc.

$10 Million plus*

Public Offering

January 2015

Read More

Vasomedical

$5 Million plus*

Public Offering

February 2015

Read More